NARB

National Advertising Review Board

NARB Recommends Novartis/GSK Discontinue Claim that Benefiber ‘Helps Maintain Regularity’

A NARB panel has recommended that Novartis Consumer Health, Inc., now a GSK Consumer Healthcare Company, discontinue the claim, made in television and print ads, that its dietary supplement product Benefiber “Helps Maintain Regularity.”

Read More

NARB Panel Recommends Clorox Discontinue Claims Challenged by OxiClean Maker Church & Dwight

A five-member panel of NARB has recommended that The Clorox Company discontinue advertising claims challenged by Church & Dwight Co., the maker of OxiClean White Revive.

Read More

NARB Panel Recommends Bayer Modify, Discontinue Certain Claims for Claritin-D

A five-member panel of NARB has recommended that Bayer HealthCare, LLC discontinue the advertising claim that nothing works faster than Claritin-D and qualify the claim that Claritin-D starts to work on allergies in 30 minutes.

Read More

NARB Panel Hears DirecTV Appeal: Even ‘Very Funny’ Advertising May Include Claims That Require Substantiation

A five-member panel of the National Advertising Review Board (NARB) has recommended that DirecTV, LLC, discontinue comparative claims in certain broadcast advertising that implied DirecTV is superior to cable with respect to signal reliability, service wait times, picture/sound quality, and sports programming. The panel also determined that certain customer-satisfaction claims made by DirecTV did not require any additional disclosures, beyond a more prominent reference to the basis of the claim to be #1 in customer satisfaction over all cable TV providers.

Read More

National Advertising Review Board Recommends Philosophy Modify or Discontinue Certain Claims for ‘Time in a Bottle’

A panel of the National Advertising Review Board (NARB) has recommended that Philosophy, Inc., modify or discontinue certain advertising claims for the company’s “Time in a Bottle Age-Defying Serum.”

Read More

NARB Panel Recommends Neogenis Laboratories Discontinue Certain Claims for Neo40 Daily Supplement

A five-member panel of the National Advertising Review Board (NARB) has recommended that Neogenis Laboratories, Inc., discontinue certain advertising claims for the company’s Neo40 Daily dietary supplement

Read More